Dr Reddys Laboratories (RDY) Gross Profit Growth (1y) (2010 - 2021)
Dr Reddys Laboratories (RDY) Gross Profit Growth (1y) (2010 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 2.43% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -8.36% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -5.56% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -3.83% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 9.27% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 38.19% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 11.92% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | 16.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 14.64% |
| Mar 31, 2021 | 2.97% |
| Sep 30, 2020 | 9.34% |
| Jun 30, 2020 | -6.46% |
| Mar 31, 2020 | 19.93% |
| Sep 30, 2019 | 10.67% |
| Jun 30, 2019 | 34.38% |
| Mar 31, 2019 | -1.75% |
| Dec 31, 2018 | 10.14% |
| Sep 30, 2018 | -8.81% |
| Dec 31, 2017 | -15.85% |
| Sep 30, 2017 | -5.19% |
| Dec 31, 2016 | 2.18% |
| Sep 30, 2016 | -2.53% |
| Dec 31, 2015 | -5.87% |
| Sep 30, 2015 | 0.28% |
| Dec 31, 2014 | 2.71% |
| Sep 30, 2014 | 2.90% |
| Mar 31, 2014 | 37.70% |
| Dec 31, 2013 | 7.44% |